Literature DB >> 5481523

Host defence mechanisms in Burkitt's lymphoma and Kaposi's sarcoma: the clinical evidence.

D P Burkitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5481523      PMCID: PMC1819954          DOI: 10.1136/bmj.4.5732.424

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Evaluation of the effect of remission plasma on untreated patients with Burkitt's lymphoma.

Authors:  L Fass; R B Herberman; J Ziegler; R H Morrow
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  THE AFRICAN LYMPHOMA: PRELIMINARY OBSERVATIONS ON RESPONSE TO THERAPY.

Authors:  D BURKITT; M S HUTT; D H WRIGHT
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

3.  Immunological studies in Kaposi's sarcoma in Uganda.

Authors:  S P Master; J F Taylor; S K Kyalwazi; J L Ziegler
Journal:  Br Med J       Date:  1970-03-07

4.  Burkitt's lymphoma: remissions following seemingly non-specific therapy.

Authors:  J David; D Burkitt
Journal:  Br Med J       Date:  1968-11-02

5.  Kaposi's sarcoma in mainland Tanzania: a report of 117 cases.

Authors:  G Slavin; H M Cameron; H Singh
Journal:  Br J Cancer       Date:  1969-06       Impact factor: 7.640

  5 in total
  4 in total

Review 1.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  In-vitro culture of Kaposi's disease cells.

Authors:  F Ottolenghi; L Andreassi; E Sbano; R Baiocchi
Journal:  Arch Dermatol Forsch       Date:  1974

Review 3.  The place of clinical chemistry in the detection of cancer.

Authors:  R R O'Moore
Journal:  Ir J Med Sci       Date:  1971-12       Impact factor: 1.568

4.  Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.

Authors:  R Evans
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.